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MicroRNAs (miRNAs) are 19–24 nt single-stranded RNAs which regulate gene
expression by sequence-specific targeting of corresponding mRNAs. Extracellular
miRNAs have been consistently detected in all human body fluids, and were shown
to be prominent non-invasive biomarkers for various diseases including cancer. Albeit
biological function of cell-free miRNA remains questionable, some studies demonstrated
that exosomes encapsulated extracellular miRNAs could mediate inter-cellular signaling.
While others suggested that these miRNAs are mostly by-products of cellular activity and
do not carry any significant biological function. This article aims to discuss the current
theories of origin of extracellular miRNA, and to highlight recent application of a novel
technique of micro-vesicles counting, that may challenge the existence of exosomal
miRNA.
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The number of reports addressing extracellular circulating miRNA has exploded in recent years,
revealing enormous interest in this emerging field. Extracellular miRNAs have been reported to
participate in a wide range of processes implying both short range and distant cell-cell communica-
tion between various healthy and cancer cell types (Valadi et al., 2007; Skog et al., 2008; Kosaka et al.,
2010; Pegtel et al., 2010; Kogure et al., 2011; Mittelbrunn et al., 2011; Chen et al., 2012; Hergenreider
et al., 2012; Montecalvo et al., 2012; Xin et al., 2012). Multiple observations that extracellular cir-
culating miRNAs could be exported by cancer cells suggested their use as promising non-invasive
biomarkers of tumorigenesis (Taylor and Gercel-Taylor, 2008; Rabinowits et al., 2009; Ohshima
et al., 2010; Cho, 2011; Cortez et al., 2011). However, the biological significance of the miRNA
encapsulated in extracellular vesicles (EV) is still unclear (Turchinovich et al., 2012).
Lawrie and colleagues pioneered the discovery of miRNAs in biological fluids while investi-
gating several tumor-associated miRNA species in serum samples from diffuse large B-cell lym-
phoma patients (Lawrie et al., 2008). They also suggested for the first time that miRNA have
potential as non-invasive biomarkers for cancer diagnosis and prediction of the outcome. How-
ever, it remained unclear whether miRNAs are derived from tumor cells or resulted from indi-
rect response to cancer. In the same year, Tewari’s group showed that both host and tumor
derived cell-free miRNA were present in plasma and serum in a remarkably stable form (Mitchell
et al., 2008). While the exact mechanism which rendered the stability of circulating miRNA was
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not addressed, the observation that many miRNAs were co-
purified with exosomes and microvesicles exported by cultured
cells (Valadi et al., 2007) provoked the hypothesis that cell-free
miRNA in plasma is protected by the EV membranes. Further-
more, Hunter and colleagues detected miRNAs in the fractions
of purified human peripheral blood microvesicles that reinforced
the above hypothesis (Hunter et al., 2008). Along with some
reports that the exchange of miRNA (and also mRNA) between
cells can be accomplished through exosome-mediated transfer,
these findings led to a revolutionary paradigm—the existence of
inter-cellular and inter-organ communication by means of EV-
encapsulated miRNAs. Nevertheless, neither report revealed the
existence of EV-free extracellular miRNA at that time.
Unexpectedly, the assumption that only EV-encapsulated
miRNAs are present in biological fluids was challenged by two
simultaneous independent studies published in 2011 and demon-
strating that 95–99% of extracellular miRNA are not only EV-free
but also associated with proteins of the argonaute (AGO) fam-
ily, in plasma/serum and cell culture media (Arroyo et al., 2011;
Turchinovich et al., 2011). Indeed, during intracellular miRNA
synthesis all mature miRNAs become associated with one of the
AGO proteins (Bartel, 2004) and, therefore, it was expected that
extracellular miRNA can be coupled with the same proteins.
Furthermore, the association of Argonaute-bound miRNAs with
both exosomes and microvesicles could in theory be explained
by the known ability of RNA-binding proteins to efficiently bind
the membranes (Agapov et al., 1997; Pohl et al., 1998). Consis-
tently, the remarkable stability of AGO2 protein explained the
resistance of associated miRNAs in cells-free nuclease and pro-
tease rich environment (Turchinovich et al., 2011). None of the
studies has addressed the copy number of the remaining 1–5%
of extracellular miRNA fractions which was indeed co-purified
with exosomes and microvesicles. Nevertheless, it became appar-
ent that the vast majority of the extracellular miRNAs cannot
mediate cell-cell communication function directly, as they were
solely AGO-proteins bound by-products of cell death (Arroyo
et al., 2011; Turchinovich et al., 2011).
A recent study by the Tewari group has significantly chal-
lenged the “exosomal miRNA hypothesis” as it revealed that most
individual exosomes in standard preparations do not carry bio-
logically significant numbers of miRNAs (Chevillet et al., 2014).
The authors used a novel nanoparticle tracking analysis (NTA)
method to quantify the abundance of extracellular exosomes, and
compared it with the molarity of accompanied miRNAs. They
quantified both exosomes and miRNA molecules number within
plasma, seminal fluid as well as conditioned media from den-
dritic cells, mast cells, and ovarian cancer cells. Strikingly, in
all analyzed samples the ratio of miRNA molecules to exosomes
was significantly less than one. More strikingly, on average, 100
exosomes corresponded to only one copy of a given miRNA.
In previous reports, the quantification of extracellular exosomes
has been performed by manual counting after visualization using
transmission electron microscopy (TEM) (Thery et al., 2006;
Valadi et al., 2007; Montecalvo et al., 2012). However, due to
complicate sample preparation process, TEM is not a “quantita-
tive” method. On the contrary, the NTA approach allows precise
quantification of exosomes under 300 nm after visualization of
light scattering induced by the particles using a light microscope
(Dragovic et al., 2011; Chevillet et al., 2014). The fact that most
individual exosomes do not carry a biologically significant num-
ber of miRNAs strongly suggest that extracellular miRNA cannot
mediate cell-cell communication by direct targeting mRNAs in
the recipient cells. However, the impact of the protein protected
miRNAs on extracellular receptors cannot be excluded.
Since Chevillet and colleagues only investigated exosomal
fractions of the extracellular fluids, their study did not exclude
a possibility that EVs larger than exosomes (e.g., microvesicles)
may contain more copies of miRNA. However, the removal of
microvesicles by either ultra-filtration or high-speed centrifu-
gation does not alter the overall levels of extracellular miRNA
in both cell-free plasma and conditioned media, indicating that
microvesicles may contain either similar or smaller amounts of
miRNA than exosomes (Turchinovich et al., 2011). More impor-
tantly, the assumption that some miRNAs are incorporated into
exosomes and microvesicles were so far solely based on observa-
tions that EV and certain miRNAs co-purify by sedimentation
or/and ultrafiltration. It remains to be tested whether EV-free
extracellular miRNA in forms of large protein aggregates (e.g.,
fully assembled RISC) co-purifies with exosomes.
Beyond cell-cell communication, the diagnostic and disease
prognostic potential of extracellular miRNA is still a very valid
area. Indeed, during toxicity in certain organs and tissues (Lat-
erza et al., 2009; Corsten et al., 2010; Zhang et al., 2010), AGO
proteins associated miRNAs are released into the extracellular
space, and travel to distant parts of the body due to the incred-
ible stability of AGO-miRNA complex (Turchinovich et al., 2011,
2013; Turchinovich and Burwinkel, 2012). Thus, in patients with
chronic hepatitis B, the increase of liver specific miR-122 in
the plasma strongly correlated with the severity of the disease.
More importantly, compared with an increase in aminotrans-
ferase activity (a common marker for liver damage) in the blood,
the increase in miR-122 concentration appeared earlier (Zhang
et al., 2010). Likewise, dying tumor cells or immune cells dur-
ing inflammation can alter the “healthy” pattern of extracellu-
lar miRNAs. Indeed, many cancer-tissue-specific miRNAs and
“inflammatory” miRNAs have been found in the blood circula-
tion at different stages of the disease (Mitchell et al., 2008; Skog
et al., 2008; Rabinowits et al., 2009; Cho et al., 2011; Olivieri et al.,
2013). However, the diagnostic promised of cell-free miRNA has
to be regarded with carefulness. Thus, Leidner and colleagues
have failed to reproduce breast cancer predictive values of many
circulating miRNAs in a genome-wide plasma miRNA profiling
experiment (Leidner et al., 2013). In addition, there is a sig-
nificant inconsistency among multiple previous studies demon-
strating cancer-associated miRNA patterns in biological fluids,
highlighting the need for better standardization of pre-analytical
factors, samples processing, miRNA profiling methods and data
analysis.
In light of the recent evidences the concept that human cells
export extracellular miRNA packed into EV has to be thoroughly
validated (Chevillet et al., 2014).While the presence of other RNA
species including tRNA, rRNA, snRNA, snoRNA, Y RNA in the
micro-vesicles and exosomes cannot be yet excluded, the current
paradigm of extracellular miRNA has to be revised and updated.
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